aTYR PHARMA INC Basic Shares Outstanding (Weighted Average)
aTYR PHARMA INC (ATYR) reported Basic Shares Outstanding (Weighted Average) of 98.07 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-07
- aTYR PHARMA INC weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 98.07M shares, a 8.82% increase year-over-year.
- aTYR PHARMA INC weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 98.04M shares, a 13.36% increase year-over-year.
- aTYR PHARMA INC weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 98.07M shares, a 18.46% increase year-over-year.
- aTYR PHARMA INC weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 97.15M shares, a 28.17% increase year-over-year.
- aTYR PHARMA INC weighted average number of shares outstanding, basic for fiscal 2025 was 92.99M shares, a 25.21% increase from fiscal 2024.
- aTYR PHARMA INC weighted average number of shares outstanding, basic for fiscal 2024 was 74.26M shares, a 38.53% increase from fiscal 2023.
- aTYR PHARMA INC weighted average number of shares outstanding, basic for fiscal 2023 was 53.61M shares, a 88.63% increase from fiscal 2022.
- aTYR PHARMA INC weighted average number of shares outstanding, basic for fiscal 2022 was 28.42M shares, a 48.94% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 98.07M shares 10-Q · filed 2026-08-07 | 98.06M shares 10-Q · filed 2026-08-07 | 98.06M shares derived: average of 3 quarters · filed 2026-08-07 | 97.83M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 98.04M shares 10-Q · filed 2026-05-15 | 98.05M shares derived: average of 2 quarters · filed 2026-05-15 | 97.75M shares derived: average of 3 quarters · filed 2026-05-15 | 95.85M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | 98.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 97.61M shares derived: average of 2 quarters · filed 2026-03-05 | 95.11M shares derived: average of 3 quarters · filed 2026-08-07 | 92.99M shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 97.15M shares 10-Q · filed 2025-11-06 | 93.64M shares derived: average of 2 quarters · filed 2026-08-07 | 91.29M shares 10-Q · filed 2025-11-06 | 89.14M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | 90.12M shares 10-Q · filed 2026-08-07 | 88.31M shares 10-Q · filed 2026-08-07 | 86.46M shares derived: average of 3 quarters · filed 2026-08-07 | 83.80M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | 86.49M shares 10-Q · filed 2026-05-15 | 84.64M shares derived: average of 2 quarters · filed 2026-05-15 | 81.69M shares derived: average of 3 quarters · filed 2026-05-15 | 79.34M shares derived: average of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | 82.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 79.29M shares derived: average of 2 quarters · filed 2026-03-05 | 76.96M shares derived: average of 3 quarters · filed 2026-03-05 | 74.26M shares 10-K · filed 2026-03-05 |
| 2024-09-30 | 75.80M shares 10-Q · filed 2025-11-06 | 74.04M shares derived: average of 2 quarters · filed 2025-11-06 | 71.42M shares 10-Q · filed 2025-11-06 | 68.37M shares derived: average of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | 72.28M shares 10-Q · filed 2025-08-07 | 69.20M shares 10-Q · filed 2025-08-07 | 65.90M shares derived: average of 3 quarters · filed 2026-03-05 | 63.89M shares derived: average of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | 66.08M shares 10-Q · filed 2025-05-07 | 62.70M shares derived: average of 2 quarters · filed 2026-03-05 | 61.10M shares derived: average of 3 quarters · filed 2026-03-05 | 59.61M shares derived: average of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | 59.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 58.60M shares derived: average of 2 quarters · filed 2026-03-05 | 57.45M shares derived: average of 3 quarters · filed 2026-03-05 | 53.61M shares 10-K · filed 2026-03-05 |
| 2023-09-30 | 57.89M shares 10-Q · filed 2024-11-07 | 56.51M shares derived: average of 2 quarters · filed 2024-11-07 | 51.70M shares 10-Q · filed 2024-11-07 | 46.01M shares derived: average of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | 55.14M shares 10-Q · filed 2024-08-13 | 48.56M shares 10-Q · filed 2024-08-13 | 42.06M shares derived: average of 3 quarters · filed 2025-03-13 | 38.71M shares derived: average of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | 41.90M shares 10-Q · filed 2024-05-02 | 35.51M shares derived: average of 2 quarters · filed 2025-03-13 | 33.23M shares derived: average of 3 quarters · filed 2025-03-13 | 31.94M shares derived: average of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | 29.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 28.89M shares derived: average of 2 quarters · filed 2025-03-13 | 28.62M shares derived: average of 3 quarters · filed 2025-03-13 | 28.42M shares 10-K · filed 2025-03-13 |
| 2022-09-30 | 28.66M shares 10-Q · filed 2023-11-09 | 28.36M shares derived: average of 2 quarters · filed 2023-11-09 | 28.18M shares 10-Q · filed 2023-11-09 | 28.11M shares derived: average of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | 28.06M shares 10-Q · filed 2023-08-09 | 27.94M shares 10-Q · filed 2023-08-09 | 27.92M shares derived: average of 3 quarters · filed 2024-03-14 | 25.48M shares derived: average of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | 27.82M shares 10-Q · filed 2023-05-09 | 27.85M shares derived: average of 2 quarters · filed 2024-03-14 | 24.62M shares derived: average of 3 quarters · filed 2024-03-14 | 22.50M shares derived: average of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | 27.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 23.02M shares derived: average of 2 quarters · filed 2024-03-14 | 20.73M shares derived: average of 3 quarters · filed 2024-03-14 | 19.08M shares 10-K · filed 2024-03-14 |
| 2021-09-30 | 18.16M shares 10-Q · filed 2022-11-14 | 17.14M shares derived: average of 2 quarters · filed 2022-11-14 | 16.15M shares 10-Q · filed 2022-11-14 | |
| 2021-06-30 | 16.13M shares 10-Q · filed 2022-08-15 | 15.12M shares 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | 14.10M shares 10-Q · filed 2021-05-14 | |||
| 2020-12-31 | 9.16M shares 10-K · filed 2023-03-14 | |||
| 2020-03-31 | 6.88M shares 10-Q · filed 2021-05-14 | |||
| 2019-03-31 | 2.42M shares 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |